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Abstract The susceptibility of vitronectin (Vn) purified from 
human plasma to digestion by matrix metalloproteinases 
(MMPs) was examined. MMP-2, -3, -7 and -9 except for MMP- 
1 degraded Vn into multiple fragments. MMP-7 showed the high- 
est activity to the substrate among these MMPs, digesting 8-, 30- 
and 44-fold more preferentially than MMP-2, -3 and -9, respec- 
tively. These data suggest that MMP-2, -3, -7 and -9 may be 
responsible for the pathological degradation and/or normal turn- 
over of Vn. 
2. Materials and methods 
2.1. Materials 
Materials were obtained as follows: Brij 35 and diisopropyl fluoro- 
phosphate from Sigma Chemical Co.: acrylamide, ethylendiamine- 
tetraacetic acid (EDTA) and SDS from Wako Chem., Japan; 4-amino- 
phenylmercuric a etate (APMA) from Aldrich Chemical Co.: heparin- 
Sepharose CL-6B from Pharmacia Biotech. The zymogens of MMP-I. 
MMP-2, MMP-3, MMP-7 and MMP-9 were purified and activated by 
incubation with APMA as described previously [6 9]. 
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1. Introduction 
Vitronectin (Vn), an extracellular matrix component  in vari- 
ous tissues, was originally identified as serum protein secreted 
from the liver [1]. However, recent studies demonstrated the 
expression of Vn mRNA in the extrahepatic tissues [2]. Vn can 
bind to plasminogen activator inhibitor type 1, plasminogen, 
complement complex, perforin and ant i thrombin III in the cir- 
culation, and to collagen and elastin microfibrils in extracellu- 
lar milieu, suggesting that Vn may play important  biological 
roles in the tissues [1]. Actually, Vn is a substrate for cellular 
adhesion and stimulates motil ity of the keratinocytes and 
smooth muscle cells, retinal neurite outgrowth, and migration 
of the embryonal  neural crest cells [3]. In pathological condi- 
tions, Vn may be implicated in the tumor cell invasion and 
metastasis, ince expression of the integrin type receptor for Vn 
is well correlated with the mal ignant phenotype of tumor cells 
such as melanoma, gl ioblastoma and lung carcinoma cells [4,5]. 
However, no information is so far available for the proteinases 
involved in turnover and pathological degradation of Vn. In the 
present study, we have examined susceptibility of Vn to five 
different matrix metal loproteinases (MMPs)  and found that it 
can be digested by MMP-2  (gelatinase A; EC 3.4.24.24), MMP-  
3 (stromelysin 1; EC 3.4.24.17), MMP-7  (matrilysin; EC 
3.4.24.23) and MMP-9  (gelatinase B; EC 3.4.24.35), but not by 
MMP- I  (tissue collagenase; EC 3.4.24.7). 
2.2. Purf/qcation ~!' vitronectin 
Purification protocol of Vn fiom human plasma was essentially the 
same as reported by Yatohgo et al. [10]. Human plasma was applied 
to heparin-Sepharose column chromatography equilibrated with 50 
mM Tris HC1, pH 7.5, and 0.15 M NaC1. The flow-through fractions 
were treated with 8 M urea and applied to the column equilibrated with 
8 M urea in the buffer. Vn bound to the column was eluted with 50 mM 
Tris-HC1, pH 7.5, 0.5 M NaC1, 5 mM EDTA and 8 M urea. The 
purified Vn showed a doublet of 75,000- and 65,000-M, bands as re- 
ported [10]. It was then dialyzed against 50 mM Tris HC1, pH 7.5, 0.15 
M NaCI, 0.05% Brij 35 and 0.02% NAN3. Alter addition of 2 mM 
diisopropyl fluorophosphate. Vn was stored at -20°C until used. 
2.3. Degradation O/Vn by MMPs 
Digestion of Vn was first carried out by incubation of the substrate 
at 37°C for up to 24 h with each MMP in an enzyme-to-substrate r tio 
of 1:30 in 50 mM Tris HC1, pH 7.5, containing 0.15 M NaCI, 10 mM 
CaC12, 0.05% Brij 35 and 0.02% NaN 3. To show the digestion frag- 
ments, MMP-I, -2, -3, -7 and -9 were incubated t\~r 4 h at 37°C with 
the substrate in enzyme-to-substrate ratios of 1: 10. 1:20, 1:10, 1:700 
and 1: 10, respectively. The reactions were terminated with 20 mM 
EDTA and the products were analyzed by SDS-polyacrylamide g l 
electrophoresis (PAGE) (10% acrylamide) under reducing conditions. 
To determine catalytic efficiency of MMP-2, -3, -7 or -9, Vn ( 10/~g) 
was incubated for 2 h at 37°C with each APMA-activated MMP in a 
final reaction mixture of 70/~1 (50 mM Tris-HC1, pH 7.5, 0.15 M NaCI, 
10 mM CaCI2, 0.05% Brij 35 and 0.02% NAN3). Seven different concen- 
trations of each MMR i.e. enzyme-to-substrate r tios of 1:25 I :150 for 
MMP-2, -3 and -9 and 1:400-1:1000 for MMP-7, were used for the 
study. After SDS-PAGE, the protein bands in the gels were stained with 
1% Coomassie Brilliant Blue and densitometrically scanned using com- 
puter assisted image analysis. The reaction velocity was quantitated by 
measuring the disappearance of 75,000- and 65,000-M,. bands of intact 
Vn, since the single cleavage product of Vn was not obtained. The 
disappearance patterns were linear with time until approximately 20 
25% of the substrate was degraded. Based on the molecular masses o1" 
51,929, 70,952, 52,220, 27,938 and 78,426 for MMP-1, -2, -3, -7 and -9, 
respectively, the extinction coefficients were calculated [8]. F~' ~'; = 1.3, 
1.9. 1.1, 1.6 and 1.3 ml/mg for MMP-1, -2, -3, -7 and -9. respectively, 
were used l\~r the studies [8]. 
*Corresponding author. Fax: (81) (762) 34-4508. 
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Abbreviations." APMA, 4-aminophenylmercuric acetate; EDTA, ethyle- 
nediaminetetraacetic acid; MMP, matrix metalloproteinase; PAGE, 
polyacrylamide gel electrophoresis; Vn, vitronectin. 
2.4. Determination q[' K,, and V ...... 
Km and l~;n, Xof Vn degradation of MMPs were determined using the 
methods described by Welgus et al. [11]. Briefly, increasing amounts of 
Vn (8, 10, 12, 14 and 16/lg) were incubated with 1.6/lg of MMP-9, 400 
ng of MMP-2 and MMP-3, or 16 ng of MMP-7 for 2 h at 37°C. The 
reaction was performed in 50 mM Tris-HC1, pH 7.5.0.15 M NaCI, 10 
mM CaCI 2, 0.05% Brij 35 and 0.02% NaN, at a final volume of 75/A. 
The reaction mixtures were subjected to SDS-PAGE under reduction 
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and the initial velocity of disappearance of the 75,000- or 65,000-M r 
bands in the gels was measured ensitometrically as described above. 
3. Results 
Proteolytic fragments of human plasma Vn by MMP-1, -2, 
-3, -7 and -9 were analyzed on SDS-PAGE under reduction. 
Among these MMPs, MMP-2, -3, -7 and -9 but not MMP-1 
digested Vn (Fig. 1). MMP-2, -3 and -9 digested it into similar 
major fragments ranging from 62,500- to 31,500-M r, although 
some minor bands were different from each other. These prod- 
ucts were resistant o further degradation even after longer 
incubation up to 24 h in a high enzyme-to-substrate ratio of 
1:10 (data not shown). On the other hand, MMP-7 
showed different digestion products ranging from 61,500- to 
22,500-M,. (Fig. 1). Longer incubation of the reaction mixture 
degraded these fragments into smaller peptides and only the 
digestion product of 22,500-M~ species remained after 24 h incu- 
bation (data not shown). These results uggest that MMP-7 has 
the strong proteolytic activity to Vn and cleaves it at different 
sites of the substrate from those by MMP-2, -3 and -9. 
The efficiency of the Vn-degrading MMPs was examined by 
incubation of Vn with different concentrations of the MMPs. 
Table 1 shows the relative catalytic efficiency of MMP-2, -3, -7 
and -9 to cause 50% cleavage of the substrate. Vn was com- 
posed of 75,000- and 65,000-Mr species in a ratio of 3.5:6.5 by 
densitometrical analysis. Both species were equally susceptible 
to digestion by all the MMPs used in this study. MMP-7 was 
the most effective nzyme; the efficiency was about 8-, 30- and 
44-fold higher than MMP-2, -3 and -9, respectively. 
The kinetic parameters, Km and K~.at, were  determined for 
MMP-2, -3, -7 and -9. Since a single initial proteolysis could not 
be obtained by lowering enzyme concentrations or tempera- 
ture, the stained gels were scanned densitometrically for the 
disappearance of intact Vn molecule. In these experiments, 
degradation of Vn was always kept to < 25% to measure initial 
velocity, even at the lowest concentration of Vn employed and 
graphed by the method of Lineweaver and Burk. K,. of each 








Fig. 1. SDS-PAGE of the reaction products of Vn by incubation with 
MMP-1, -2, -3, -7 and -9. The substrate (10 pg) was incubated with 
MMP-1 (1 pg, lane 2), MMP-2 (0.5 fig, lane 3), MMP-3 (1 fig, lane 4), 
MMP-7 (14 ng, lane 5), or MMP-9 (1 ~ug, lane 6) for 4 h at 37°C. After 
termination ofthe reaction with 20 mM EDTA, the digestion products 
were subjected to SDS-PAGE (I0% acrylamide) under eduction and 
stained with 1% Coomassie Brilliant Blue. Lanes 1 and 7 are the control 
samples incubated with buffer alone for 0 and 4 h, respectively. 
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Table 1 
Catalytic efficiency of vitronectin by matrix metalloproteinases 
Metalloproteinase Mol of enzyme producing 50% 
degradation of vitronectin 
65,000-Mr form 75,000-M r form 
of vitronectin of vitronectin 
MMP-2 4.6 x 10 -l-' 3.7 x 10 -12 
MMP-3 1.5 x IW u 1.5 x 10 <l 
MMP-7 5.2 x 10 -I~ 4.7 x l0 <~ 
MMP-9 2.3 x 10 -I~ 2.1 x 10 -It 
Each metalloproteinase was incubated with vitronectin (10,ug) at 37°C 
for 2 h using different enzyme concentrations as described in section 
2. Degradation was extrapolated linearly to estimate the number of 
metalloproteinase required to produce 50% substrate cleavage. 
MMP for both 65,000- and 75,000-M r species of Vn was ap- 
proximately equal (Table 2). Values for K~,, were observed 
within the range of 0.03 1.2 molecules of 65,000-M r Vn/mole- 
cule of MMP/min and 0.02 1.1 molecules of 75,000-M,. Vn/ 
molecule of MMP/min. K~,,t/K,,, an index of specific activity, 
ranged from 2.0 x 104 M I rain -t to 0.9 x 106 M ~ rain < for the 
65,000-M,. species and for 2.0 x l0  4 M ~ rain < to 1.1 x 106 M 
m in-t tbr the 75,000-M r species. The value of Kc~,/K,, of M M P-7 
was approximately 11-, 30- and 50-fold higher than that of 
MMP-2, -3 and -9, respectively. 
4. Discussion 
The present study is the first to demonstrate he proteolytic 
degradation of Vn. Among five MMPs used, i.e. MMP-I ,  -2, 
-3, -7 and -9, all but MMP-1 cleaved Vn, suggesting that Vn is 
a susceptible substrate of the MMP family members. Although 
MMP-3 and -7 share the substrates, degradation products of 
the extracellular matrix macromolecules such as fibronectin 
and laminin by the enzymes are dissimilar [8,12] and the diges- 
tion patterns of Vn are also different. Recent studies have 
indicated that MMP-7 has the highest activity against cartilage 
link protein, aggrecan, entactin, insoluble lastin, and tenascin 
[8,13 17]. The present study further demonstrates that MMP-7 
is also the most effective nzyme for Vn digestion with 8-, 30- 
and 44-fold higher activities than MMP-2, -3 and -9, respec- 
tively. The data showing that the values of Km of MMP-2, -3, 
-7 and -9 against 65,000- or 75,000-M r species of Vn 
(1.0 ~ 1.5 x 10 6 M) are almost identical indicate similar bind- 
ing activities of these MMPs to Vn. It is definite that the high 
specific activity of MMP-7 to Vn is ascribed to its catalytic 
activity. However, the precise molecular mechanism is un- 
known at the present ime. It may be possible to speculate that 
this is because MMP-7 which lacks the COOH-terminal Vn-like 
domain can readily access the substrate. MMP-2 and -9 are 
structurally related and share the substrates uch as gelatins 
and type IV and V collagens. However, our previous studies 
showed that MMP-2 degrades glycoproteins including laminin 
and fibronectin while MMP-9 cleaves type III collagen and ~2 
chain of type I collagen [6,9]. For the degradation ofVn MMP- 
2 was more effective enzyme than MMP-9, but both showed 
similar digestion products, suggesting the cleavage at the simi- 
lar sites. MMP-1 was considered to exclusively hydrolyze fibril- 
lar collagens, but recent studies have shown that it also digests 
other proteins including aggrecan, entactin, cartilage link pro- 
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Table 2 
Kinetic parameters of MMPs on Vn 
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Metalloproteinase K m (M) K~,. K~,]K,, 
(tool of vitronectin digested/tool (M 7min ~) 
of enzyme/min) 
65,000-M r lk~rm 75,000-M, form 65,000-M~ form 75,000-M. t'orm 65,0(10-M, form 75.11(/0-),1, Ik~rm 
of vitronectin of vitronectin of vitronectin of vitronectin of x itronectin of vitronectin 
MMP-2 1.2 x 10 ~' l.O x 10 6 0.1 0.1 8.0 x 1(14 I.O × 10' 
MMP-3 1.5 x 1(1 ~' 1.4x 10 <' (}.!15 0.05 3.4 x 104 3.5 × lit' 
MMP-7 1.4x 10 ~' 1.0x 10 ~' 1.2 I.I 0.9× 10" 1.1 × I(I ~' 
MMP-9 1.5 × I0 " 1.3 x I0 -~' (1.113 0.(12 2.0 ,< l(P 231 × I()' 
The K,, and K,~,, of metalloproteinases on both 65,000- and 75,000-M, species ofxitronectin were determined as described in section 2 The ratio K~.,,/K,,, 
is used as an index of specitic activity. 
tein, and tenascin [13 15,17], However, Vn is not a substrate 
for the enzyme. 
Vn is known to be localized in the loose connective tissue, 
dermis, and atherosclerotic arterial wall [1]. Because of the 
wide distribution in eleastin-containing tissues and the proper- 
ties to interact with other extracellular matrix proteins, it is 
considered to serve as a molecular link between elastic fibers 
and the surrounding collagen/proteoglycan scaffold [1]. Vn is 
also a ligand for cell adhesion through integrins, urokinase 
receptor and/or cell surfitce-associated proteoglycan [1]. The 
expression of the intergrins for Vn in tumor cells is closely 
related with their invasive and metastatic phenotype [4]. In the 
current study, we have shown that MMP-2,  -3, -7 and -9 de- 
grade Vn. Since these MMPs  are expressed in the tissues of 
artherosclerotic region, wound healing and cancer [19], they 
would degrade Vn under such pathological conditions. Actu- 
ally, it has been reported that Vn extracted from the human 
adult dermis is composed of the degraded fragments with M~ 
58,000, 50,000, 42,000, 35,000 and 27,000 [20], which appear to 
be similar to those obtained by digestion with MMPs.  In addi- 
tion, Seftor et al. [21] reported that treatment of melanoma cells 
with Vn or antibodies to the Vn receptor induces MMP-2 
expression, enhancing cellular invasion through reconstituted 
basement membrane. Thus, it seems likely that MMPs  may 
participate in the degradation and/or turnover of Vn in the 
tissues under the pathophysiological conditions and also mod- 
ulate tumor cell inwtsion through degradation of Vn. 
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